Camilla Rasmussen

734 total citations
9 papers, 549 citations indexed

About

Camilla Rasmussen is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Camilla Rasmussen has authored 9 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Oncology. Recurrent topics in Camilla Rasmussen's work include Virus-based gene therapy research (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and CAR-T cell therapy research (3 papers). Camilla Rasmussen is often cited by papers focused on Virus-based gene therapy research (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and CAR-T cell therapy research (3 papers). Camilla Rasmussen collaborates with scholars based in United States, United Kingdom and Canada. Camilla Rasmussen's co-authors include Henrik Rasmussen, Ralph R. Weichselbaum, Jennifer Macko, Karen Chu, Neil Senzer, John Nemunaitis, Donald Küfe, Alexander S. Rosemurgy, Chandan Guha and Casey Cunningham and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Drug Discovery Today.

In The Last Decade

Camilla Rasmussen

9 papers receiving 534 citations

Peers

Camilla Rasmussen

MB

GENET

ONCOL

SURGE

IMMUN

Alfred B. Bahnson United States

Deborah J. Marshall United States

Aude Le Roux France

Nobuyuki Kusaka Japan

Joe Hasei Japan

N Satake Japan

James J. Mulé United States

Hagit Yotvat Israel

G P Siegal United States

Markus D. Sachs Germany

Alfred B. Bahnson United States

Camilla Rasmussen

263 ×0.8

MB

255 ×1.3

GENET

124 ×0.7

ONCOL

59 ×0.7

SURGE

80 ×1.0

IMMUN

Citations per year, relative to Camilla Rasmussen Camilla Rasmussen (= 1×) peers Alfred B. Bahnson

Countries citing papers authored by Camilla Rasmussen

Since Specialization

Citations

This map shows the geographic impact of Camilla Rasmussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Rasmussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Rasmussen more than expected).

Fields of papers citing papers by Camilla Rasmussen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Rasmussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Rasmussen. The network helps show where Camilla Rasmussen may publish in the future.

Co-authorship network of co-authors of Camilla Rasmussen

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Rasmussen. A scholar is included among the top collaborators of Camilla Rasmussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Rasmussen. Camilla Rasmussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Stewart, Duncan J., Adrian Hilton, Jennifer M. Arnold, et al.. (2006). Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment. Gene Therapy. 13(21). 1503–1511. 194 indexed citations

2.

Qian, David Z., Mingqiang Ren, Xiaofei Wang, et al.. (2005). In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS‐275 in retinoid‐resistant prostate cancer cells. The Prostate. 64(1). 20–28. 29 indexed citations

3.

Mundt, Arno J., Srinivasan Vijayakumar, John Nemunaitis, et al.. (2004). A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities. Clinical Cancer Research. 10(17). 5747–5753. 72 indexed citations

4.

Senzer, Neil, Sridhar Mani, Alexander S. Rosemurgy, et al.. (2004). TNFerade Biologic, an Adenovector With a Radiation-Inducible Promoter, Carrying the Human Tumor Necrosis Factor Alpha Gene: A Phase I Study in Patients With Solid Tumors. Journal of Clinical Oncology. 22(4). 592–601. 149 indexed citations

5.

Rasmussen, Henrik, et al.. (2002). TNFerade Biologic: Preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene. Cancer Gene Therapy. 9(11). 951–957. 64 indexed citations

6.

Rasmussen, Henrik, et al.. (2002). Angiogenic gene therapy strategies for the treatment of cardiovascular disease.. PubMed. 4(5). 476–81. 11 indexed citations

7.

Rasmussen, Henrik, Camilla Rasmussen, & Jennifer Macko. (2002). VEGF gene therapy for coronary artery disease and peripheral vascular disease. 3(2). 114–117. 22 indexed citations

8.

Rasmussen, Henrik, et al.. (2001). Looking into anti-angiogenic gene therapies for disorders of the eye. Drug Discovery Today. 6(22). 1171–1175. 4 indexed citations

9.

Rasmussen, Henrik & Camilla Rasmussen. (1965). Danmarks undergrund. 1965(3). 11–22. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact